Pharming Group to participate in June investor conferences

Rhea-AI Summary

Pharming Group N.V. (Euronext: PHARM/Nasdaq: PHAR) has announced its management's participation in two key investor conferences in June 2025. The company will attend the Jefferies Global Healthcare Conference in New York on June 4-5, where CEO Fabrice Chouraqui will participate in a Fireside Chat Q&A session on June 5 at 2:00 pm EDT/20:00 CEST. Additionally, Pharming will participate in the Portzamparc Mid & Small Caps Conference in Paris on June 18.

Investors can access the Jefferies conference presentation via live webcast and replay through Pharming's website. Those interested in one-on-one meetings with management can arrange them through Pharming's IR team or their Jefferies or Portzamparc representatives.

Leiden, the Netherlands, May 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conferences in the month of June:

• Jefferies Global Healthcare Conference 2025, New York, USA, June 4-5, 2025
  Fabrice Chouraqui, Chief Executive Officer, will participate in a Fireside Chat Q&A session on Thursday, June 5 at 2:00 pm EDT/20:00 CEST. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.
• Portzamparc (BNP Paribas) Mid & Small Caps Conference, Paris, France, June 18, 2025

For more information about these conferences, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Jefferies or Portzamparc representative.

About Pharming Group N.V.

Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are commercializing and developing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.

For more information, visit www.pharming.com and find us on LinkedIn.

For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com

FTI Consulting, London, United Kingdom
Simon Conway/Alex Shaw/Amy Byrne
T: +44 203 727 1000

LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl

Attachment

• Pharming attending Investor Conferences June 2025_EN_28MAY25

FAQ

What investor conferences will Pharming Group (PHAR) attend in June 2025?

Pharming Group will attend the Jefferies Global Healthcare Conference in New York (June 4-5) and the Portzamparc Mid & Small Caps Conference in Paris (June 18).

When is Pharming Group's CEO presenting at the Jefferies Healthcare Conference 2025?

CEO Fabrice Chouraqui will participate in a Fireside Chat Q&A session on Thursday, June 5 at 2:00 pm EDT/20:00 CEST.

How can investors access Pharming Group's presentation at the Jefferies conference?

Investors can access the live webcast and replay of the presentation through the 'Upcoming Events' and 'News' sections of Pharming's website.

How can investors schedule meetings with Pharming Group's management at these conferences?

Investors can schedule one-on-one meetings by contacting Pharming's Investor Relations team at investor@pharming.com or through their Jefferies or Portzamparc representative.